Ujjwal Neogi

Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Artiklar

Article: ALLERGY. 2024;79(7):1938-1951

Association between gut microbiota development and allergy in infants born during pandemic-related social distancing restrictions

Korpela K; Hurley S; Ford SA; Franklin R; Byrne S; Lunjani N; Forde B; Neogi U; Venter C; Walter J; Hourihane J; O'Mahony L
Article: ISCIENCE. 2024;27(4):109346

Inflammatory, metabolic, and sex-dependent gene-regulatory dynamics of microglia and macrophages in neonatal hippocampus after hypoxia-ischemia

Di Martino E; Ambikan A; Ramskold D; Umekawa T; Giatrellis S; Vacondio D; Romero AL; Galan MG; Sandberg R; Aden U; Lauschke VM; Neogi U; Blomgren K; Kele J
Article: NATURE COMMUNICATIONS. 2024;15(1):2532

Parechovirus infection in human brain organoids: host innate inflammatory response and not neuro-infectivity correlates to neurologic disease

Capendale PE; Garcia-Rodriguez I; Ambikan AT; Mulder LA; Depla JA; Freeze E; Koen G; Calitz C; Sood V; de Sa RV; Neogi U; Pajkrt D; Sridhar A; Wolthers KC
Article: VIRUS RESEARCH. 2024;341:199306

Temporal cytokine storm dynamics in dengue infection predicts severity

Bhatt P; Varma M; Sood V; Ambikan A; Jayaram A; Babu N; Gupta S; Mukhopadhyay C; Neogi U
Article: ALLERGY. 2024;79(1):65-79

Rural and urban exposures shape early life immune development in South African children with atopic dermatitis and nonallergic children

Lunjani N; Ambikan AT; Hlela C; Levin M; Mankahla A; Heldstab-Kast JI; Boonpiyathad T; Tan G; Altunbulakli C; Gray C; Nadeau KC; Neogi U; Akdis CA; O'Mahony L
Article: AGING CELL. 2023;22(10):e13951

Transcriptomics age acceleration in prolonged treated HIV infection

Mikaeloff F; Gelpi M; Escos A; Knudsen AD; Hogh J; Benfield T; de Magalhaes JP; Nielsen SD; Neogi U
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2023;120(37):e2304722120

Systems-level temporal immune- metabolic profile in Crimean-Congo hemorrhagic fever virus infection

Ambikan AT; Elaldi N; Akusjaervi SS; Bagci B; Pektas AN; Hewson R; Bagci G; Arasli M; Appelberg S; Mardinoglu A; Sood V; Vegvari A; Benfeitas R; Gupta S; Cetin I; Mirazimi A; Neogi U
Article: JMIR RESEARCH PROTOCOLS. 2023;12:e47018

Testing the Impact of Phone Texting Reminders for Children's Immunization Appointments in Rural Cameroon: Protocol for a Nonrandomized Controlled Trial

Ngah YE; Raoufi G; Amirkhani M; Esmaeili A; Nikooifard R; Mood SG; Rahmanian A; Boltena MT; Aga E; Neogi U; Mondinde GI; El-Khatib Z
Article: AIDS. 2023;37(7):1023-1033

Role of myeloid cells in system-level immunometabolic dysregulation during prolonged successful HIV-1 treatment

Svensson Akusjarvi S; Krishnan S; Ambikan AT; Mikaeloff F; Munusamy Ponnan S; Vesterbacka J; Lourda M; Nowak P; Sonnerborg A; Neogi U
Article: CURRENT HIV/AIDS REPORTS. 2023;20(2):42-50

Biological Aging in People Living with HIV on Successful Antiretroviral Therapy: Do They Age Faster?

Akusjaervi SS; Neogi U
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2023;120(12):e2220320120

Functional SARS-CoV-2 cross-reactive CD4⁺ T cells established in early childhood decline with age

Humbert M; Olofsson A; Wullimann D; Niessl J; Hodcroft EB; Cai C; Gao Y; Sohlberg E; Dyrdak R; Mikaeloff F; Neogi U; Albert J; Malmberg K-J; Lund-Johansen F; Aleman S; Bjorkhem-Bergman L; Jenmalm MC; Ljunggren H-G; Buggert M; Karlsson AC
Article: ELIFE. 2023;12:e82785

Network-based multi-omics integration reveals metabolic at-risk profile within treated HIV-infection

Mikaeloff F; Gelpi M; Benfeitas R; Knudsen AD; Vestad B; Hogh J; Hov JR; Benfield T; Murray D; Giske CG; Mardinoglu A; Troseid M; Nielsen SD; Neogi U; Hens N
Article: FRONTIERS IN MICROBIOLOGY. 2023;14:1172340

Composition of subgingival microbiota associated with periodontitis and diagnosis of malignancy-a cross-sectional study

Narayanan A; Soder B; Meurman J; Lundmark A; Hu YOO; Neogi U; Yucel-Lindberg T
Article: GUT MICROBES. 2022;14(1):2073131

A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2

Albrich WC; Ghosh TS; Ahearn-Ford S; Mikaeloff F; Lunjani N; Forde B; Suh N; Kleger G-R; Pietsch U; Frischknecht M; Garzoni C; Forlenza R; Horgan M; Sadlier C; Negro TR; Pugin J; Wozniak H; Cerny A; Neogi U; O'Toole PW; O'Mahony L
Article: LIFE SCIENCE ALLIANCE. 2022;5(9):e202201405

Genome-scale metabolic models for natural and long-term drug-induced viral control in HIV infection

Ambikan AT; Svensson-Akusjarvi S; Krishnan S; Sperk M; Nowak P; Vesterbacka J; Sonnerborg A; Benfeitas R; Neogi U
Article: CELL SYSTEMS. 2022;13(8):665-681.e4

Multi-omics personalized network analyses highlight progressive disruption of central metabolism associated with COVID-19 severity

Ambikan AT; Yang H; Krishnan S; Akusjarvi SS; Gupta S; Lourda M; Sperk M; Arif M; Zhang C; Nordqvist H; Ponnan SM; Sonnerborg A; Treutiger CJ; O'Mahony L; Mardinoglu A; Benfeitas R; Neogi U
Article: ELIFE. 2022;11:e76071

Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo hemorrhagic fever viruses for novel therapeutic target

Neogi U; Elaldi N; Appelberg S; Ambikan A; Kennedy E; Dowall S; Bagci BK; Gupta S; Rodriguez JE; Svensson-Akusjarvi S; Monteil V; Vegvari A; Benfeitas R; Banerjea A; Weber F; Hewson R; Mirazimi A
Article: COMMUNICATIONS BIOLOGY. 2022;5(1):357

Peripheral blood CD4⁺CCR6⁺ compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals

Svensson Akusjarvi S; Krishnan S; Jutte BB; Ambikan AT; Gupta S; Rodriguez JE; Vegvari A; Sperk M; Nowak P; Vesterbacka J; Svensson JP; Sonnerborg A; Neogi U
Article: VIROLOGY. 2022;569:13-28

Azadirachta indica A. Juss bark extract and its Nimbin isomers restrict β-coronaviral infection and replication

Sarkar L; Oko L; Gupta S; Bubak AN; Das B; Gupta P; Safiriyu AA; Singhal C; Neogi U; Bloom D; Banerjee A; Mahalingam R; Cohrs RJ; Koval M; Shindler KS; Pal D; Nagel M; Das Sarma J
Article: JOURNAL OF VIROLOGY. 2022;96(3):e0156821-e01521

Nucleoside-Modified mRNA Vaccines Protect IFNAR^-/- Mice against Crimean-Congo Hemorrhagic Fever Virus Infection

Appelberg S; John L; Pardi N; Vegvari A; Bereczky S; Ahlen G; Monteil V; Abdurahman S; Mikaeloff F; Beattie M; Tam Y; Sallberg M; Neogi U; Weissman D; Mirazimi A
Article: ISCIENCE. 2022;25(1):103607

Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: A cross-talk between glycolysis and HIF signaling

Akusjarvi SS; Ambikan AT; Krishnan S; Gupta S; Sperk M; Vegvari A; Mikaeloff F; Healy K; Vesterbacka J; Nowak P; Sonnerborg A; Neogi U
Article: COMMUNICATIONS BIOLOGY. 2022;5(1):27

Trans cohort metabolic reprogramming towards glutaminolysis in long-term successfully treated HIV-infection

Mikaeloff F; Akusjarvi SS; Ikomey GM; Krishnan S; Sperk M; Gupta S; Magdaleno GDV; Escos A; Lyonga E; Okomo MC; Tagne CT; Babu H; Lorson CL; Vegvari A; Banerjea AC; Kele J; Hanna LE; Singh K; de Magalhaes JP; Benfeitas R; Neogi U
Article: HRB OPEN RESEARCH. 2022;5:31

Impact of Long COVID on health and quality of life.

O' Mahony L; Buwalda T; Blair M; Forde B; Lunjani N; Ambikan A; Neogi U; Barrett P; Geary E; O'Connor N; Dineen J; Clarke G; Kelleher E; Horgan M; Jackson A; Sadlier C
Article: MICROBIOLOGY SPECTRUM. 2021;9(2):e0054921-e00521

Distinct Metabolic Profile Associated with a Fatal Outcome in COVID-19 Patients during the Early Epidemic in Italy

Saccon E; Bandera A; Sciume M; Mikaeloff F; Lashari AA; Aliberti S; Sachs MC; Billi F; Blasi F; Gabriel EE; Costantino G; De Roberto P; Krishnan S; Gori A; Peyvandi F; Scudeller L; Canetta C; Lorson CL; Valenti L; Singh K; Baldini L; Fracchiolla NS; Neogi U
Article: MICROBIOLOGY SPECTRUM. 2021;9(2):e0047021-e00421

Deciphering the Role of Mucosal Immune Responses and the Cervicovaginal Microbiome in Resistance to HIV Infection in HIV-Exposed Seronegative (HESN) Women

Ponnan SM; Thiruvengadam K; Tellapragada C; Ambikan AT; Narayanan A; Kathirvel S; Mathayan M; Shankar J; Rajaraman A; Amanulla MA; Dinesha TR; Poongulali S; Saravanan S; Murugavel KG; Swaminathan S; Velu V; Shacklett B; Neogi U; Hanna LE
Article: HUMAN MOLECULAR GENETICS. 2021;30(21):2012-2026

Coordinated pyruvate kinase activity is crucial for metabolic adaptation and cell survival during mitochondrial dysfunction

Zhou X; Mikaeloff F; Curbo S; Zhao Q; Kuiper R; Vegvari A; Neogi U; Karlsson A
Article: AGING-US. 2021;13(19):22732-22751

The central role of the glutamate metabolism in long-term antiretroviral treated HIV-infected individuals with metabolic syndrome

Gelpi M; Mikaeloff F; Knudsen AD; Benfeitas R; Krishnan S; Akusjarvi SS; Hogh J; Murray DD; Ullum H; Neogi U; Nielsen SD
Article: JOURNAL OF VIROLOGY. 2021;95(18):e0047921-10.1128/jvi.00421

Fecal Metabolome Signature in the HIV-1 Elite Control Phenotype: Enrichment of Dipeptides Acts as an HIV-1 Antagonist but a Prevotella Agonist

Sperk M; Ambikan AT; Ray S; Singh K; Mikaeloff F; Diez RC; Narayanan A; Vesterbacka J; Nowak P; Sonnerborg A; Neogi U
Article: ISCIENCE. 2021;24(5):102420

Cell-type-resolved quantitative proteomics map of interferon response against SARS-CoV-2

Saccon E; Chen X; Mikaeloff F; Rodriguez JE; Szekely L; Vinhas BS; Krishnan S; Byrareddy SN; Frisan T; Vegvari A; Mirazimi A; Neogi U; Gupta S
Article: CELL DEATH DISCOVERY. 2021;7(1):114

Type-I interferon signatures in SARS-CoV-2 infected Huh7 cells

Chen X; Saccon E; Appelberg KS; Mikaeloff F; Rodriguez JE; Vinhas BS; Frisan T; Vegvari A; Mirazimi A; Neogi U; Gupta S
Article: ACS INFECTIOUS DISEASES. 2021;7(5):1104-1115

Altered Gut Microbiome under Antiretroviral Therapy: Impact of Efavirenz and Zidovudine

Ray S; Narayanan A; Giske CG; Neogi U; Sonnerborg A; Nowak P
Article: BMC INFECTIOUS DISEASES. 2021;21(1):214

Increased acquired protease inhibitor drug resistance mutations in minor HIV-1 quasispecies from infected patients suspected of failing on national second-line therapy in South Africa

Obasa AE; Ambikan AT; Gupta S; Neogi U; Jacobs GB
Article: ISCIENCE. 2021;24(2):102111

Distinct lipid profile, low-level inflammation, and increased antioxidant defense signature in HIV-1 elite control status

Sperk M; Mikaeloff F; Svensson-Akusjarvi S; Krishnan S; Ponnan SM; Ambikan AT; Nowak P; Sonnerborg A; Neogi U
Article: AIDS. 2021;35(2):227-234

High-throughput sequencing reveals a high prevalence of pretreatment HIV-1 drug resistance in Sweden

Andersson E; Ambikan A; Brannstrom J; Aralaguppe SG; Yilmaz A; Albert J; Neogi U; Sonnerborg A
Article: FRONTIERS IN IMMUNOLOGY. 2021;12:742736

Integrative Lipidomics and Metabolomics for System-Level Understanding of the Metabolic Syndrome in Long-Term Treated HIV-Infected Individuals

Olund Villumsen S; Benfeitas R; Knudsen AD; Gelpi M; Hogh J; Thomsen MT; Murray D; Ullum H; Neogi U; Nielsen SD
Article: FRONTIERS IN MICROBIOLOGY. 2021;12:667718

Whole-Genome Metagenomic Analysis of the Gut Microbiome in HIV-1-Infected Individuals on Antiretroviral Therapy

Bai X; Narayanan A; Nowak P; Ray S; Neogi U; Sonnerborg A
Article: FRONTIERS IN IMMUNOLOGY. 2021;12:669347

Cytotoxic Lymphocytes Target HIV-1 Gag Through Granzyme M-Mediated Cleavage

Saccon E; Mikaeloff F; Ivern PF; Vegvari A; Sonnerborg A; Neogi U; van Domselaar R
Article: FRONTIERS IN IMMUNOLOGY. 2021;12:638144

Elevated Numbers of HIV-Specific Poly-Functional CD8⁺ T Cells With Stem Cell-Like and Follicular Homing Phenotypes in HIV-Exposed Seronegative Individuals

Munusamy Ponnan S; Thiruvengadam K; Kathirvel S; Shankar J; Rajaraman A; Mathaiyan M; Dinesha TR; Poongulali S; Saravanan S; Murugavel KG; Swaminathan S; Tripathy SP; Neogi U; Velu V; Hanna LE
Article: MOLECULAR & CELLULAR PROTEOMICS. 2021;20:100159

Metabolic Perturbation Associated With COVID-19 Disease Severity and SARS-CoV-2 Replication

Krishnan S; Nordqvist H; Ambikan AT; Gupta S; Sperk M; Svensson-Akusjarvi S; Mikaeloff F; Benfeitas R; Saccon E; Ponnan SM; Rodriguez JE; Nikouyan N; Odeh A; Ahlen G; Asghar M; Sallberg M; Vesterbacka J; Nowak P; Vegvari A; Sonnerborg A; Treutiger CJ; Neogi U
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2020;36(12):1024-1032

Deep Profiling Identifies Selection of Nonsynonymous Amino Acid Substitutions in HIV-1 Envelope During Early Infection

Ashokkumar M; Pattabiraman S; Tripathy SP; Neogi U; Hanna LE
Article: EMERGING MICROBES & INFECTIONS. 2020;9(1):1748-1760

Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells

Appelberg S; Gupta S; Svensson Akusjarvi S; Ambikan AT; Mikaeloff F; Saccon E; Vegvari A; Benfeitas R; Sperk M; Stahlberg M; Krishnan S; Singh K; Penninger JM; Mirazimi A; Neogi U
Article: BIOSENSORS & BIOELECTRONICS. 2020;166:112442

Sub-attomole detection of HIV-1 using padlock probes and rolling circle amplification combined with microfluidic affinity chromatography

Soares RRG; Varela JC; Neogi U; Ciftci S; Ashokkumar M; Pinto IF; Nilsson M; Madaboosi N; Russom A
Article: PATHOGENS. 2020;9(5):E320-320

Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs

Neogi U; Hill KJ; Ambikan AT; Heng X; Quinn TP; Byrareddy SN; Soennerborg A; Sarafianos SG; Singh K
Article: SCIENTIFIC REPORTS. 2020;10(1):2747

In vitro replicative fitness of early Transmitted founder HIV-1 variants and sensitivity to Interferon alpha

Ashokkumar M; Sonawane A; Sperk M; Tripathy SP; Neogi U; Hanna LE
Article: CLINICAL INFECTIOUS DISEASES. 2020;70(4):615-627

The Impact of Human Immunodeficiency Virus Infection on Gut Microbiota α-Diversity: An Individual-level Meta-analysis.

Tuddenham SA; Koay WLA; Zhao N; White JR; Ghanem KG; Sears CL; HIV Microbiome Re-analysis Consortium
Article: COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL. 2020;18:3734-3744

In silico and in vitro studies reveal complement system drives coagulation cascade in SARS-CoV-2 pathogenesis

Tiwari R; Mishra AR; Mikaeloff F; Gupta S; Mirazimi A; Byrareddy SN; Neogi U; Nayak D
Article: FRONTIERS IN MICROBIOLOGY. 2020;11:438

Drug Resistance Mutations Against Protease, Reverse Transcriptase and Integrase Inhibitors in People Living With HIV-1 Receiving Boosted Protease Inhibitors in South Africa

Obasa AE; Mikasi SG; Brado D; Cloete R; Singh K; Neogi U; Jacobs GB
Article: METABOLITES. 2019;9(10):E210-210

Plasma Metabolic Signature and Abnormalities in HIV-Infected Individuals on Long-Term Successful Antiretroviral Therapy

Babu H; Sperk M; Ambikan AT; Rachel G; Viswanathan VK; Tripathy SP; Nowak P; Hanna LE; Neogi U
Article: AIDS. 2019;33(11):1757-1763

HIV elite control is associated with reduced TRAILshort expression

Paim AC; Cummins NW; Natesampillai S; Garcia-Rivera E; Kogan N; Neogi U; Sonnerborg A; Sperk M; Bren GD; Deeks S; Polley E; Badley AD
Article: VIRUSES-BASEL. 2019;11(9):E806-806

MiDRMpol: A High-Throughput Multiplexed Amplicon Sequencing Workflow to Quantify HIV-1 Drug Resistance Mutations against Protease, Reverse Transcriptase, and Integrase Inhibitors

Aralaguppe SG; Ambikan AT; Ashokkumar M; Kumar MM; Hanna LE; Amogne W; Sonnerborg A; Neogi U
Article: BMC INFECTIOUS DISEASES. 2019;19(1):569

A viral genome wide association study and genotypic resistance testing in patients failing first line antiretroviral therapy in the first large countrywide Ethiopian HIV cohort

Telele NF; Kalu AW; Gebre-Selassie S; Fekade D; Marrone G; Grossmann S; Neogi U; Tegbaru B; Sonnerborg A
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2019;35(6):572-576

Mutations in Long Terminal Repeats κB Transcription Factor Binding Sites in Plasma Virus Among South African People Living with HIV-1

Obasa AE; Ashokkumar M; Neogi U; Jacobs GB
Article: JOURNAL OF VIROLOGY. 2019;93(9):e00077-e00019

HIV-1 Subtype C with PYxE Insertion Has Enhanced Binding of Gag-p6 to Host Cell Protein ALIX and Increased Replication Fitness

van Domselaar R; Njenda DT; Rao R; Sonnerborg A; Singh K; Neogi U
Article: LAB ON A CHIP. 2019;19(9):1657-1664

Microfluidic centrifugation assisted precipitation based DNA quantification

Banerjee I; Aralaguppe SG; Lapins N; Zhang W; Kazemzadeh A; Sonnerborg A; Neogi U; Russom A
Article: AIDS. 2019;33(3):588-592

Strain-specific effect on biphasic DNA binding by HIV-1 integrase

Hill KJ; Rogers LC; Njenda DT; Burke DH; Sarafianos SG; Sonnerborg A; Neogi U; Singh K
Article: FRONTIERS IN IMMUNOLOGY. 2019;10:1965

Systemic Inflammation and the Increased Risk of Inflamm-Aging and Age-Associated Diseases in People Living With HIV on Long Term Suppressive Antiretroviral Therapy

Babu H; Ambikan AT; Gabriel EE; Akusjarvi SS; Palaniappan AN; Sundaraj V; Mupanni NR; Sperk M; Cheedarla N; Sridhar R; Tripathy SP; Nowak P; Hanna LE; Neogi U
Article: FRONTIERS IN MICROBIOLOGY. 2019;10:1227

GS-CA Compounds: First-In-Class HIV-1 Capsid Inhibitors Covering Multiple Grounds

Singh K; Gallazzi F; Hill KJ; Burke DH; Lange MJ; Quinn TP; Neogi U; Sonnerborg A
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2018;73(10):2721-2728

Antiretroviral potency of 4'-ethnyl-2'-fluoro-2'-deoxyadenosine, tenofovir alafenamide and second-generation NNRTIs across diverse HIV-1 subtypes

Njenda DT; Aralaguppe SG; Singh K; Rao R; Sonnerborg A; Sarafianos SG; Neogi U
Article: AIDS. 2018;32(12):1589-1598

The microbial metabolite trimethylamine-N-oxide in association with inflammation and microbial dysregulation in three HIV cohorts at various disease stages

Missailidis C; Neogi U; Stenvinkel P; Troseid M; Nowak P; Bergman P
Article: SCIENTIFIC REPORTS. 2018;8(1):7556

Pretreatment drug resistance in a large countrywide Ethiopian HIV-1C cohort: a comparison of Sanger and high-throughput sequencing

Telele NF; Kalu AW; Gebre-Selassie S; Fekade D; Abdurahman S; Marrone G; Neogi U; Tegbaru B; Sonnerborg A
Article: JOURNAL OF VIROLOGY. 2018;92(9):e00063-e00018

Unique Phenotypic Characteristics of Recently Transmitted HIV-1 Subtype C Envelope Glycoprotein gp120: Use of CXCR6 Coreceptor by Transmitted Founder Viruses

Ashokkumar M; Aralaguppe SG; Tripathy SP; Hanna LE; Neogi U
Article: SCIENTIFIC REPORTS. 2018;8(1):4709

Analyses of HIV-1 integrase sequences prior to South African national HIV-treatment program and available of integrase inhibitors in Cape Town, South Africa

Brado D; Obasa AE; Ikomey GM; Cloete R; Singh K; Engelbrecht S; Neogi U; Jacobs GB
Article: AIDS. 2018;32(4):469-476

Ex-vivo antiretroviral potency of newer integrase strand transfer inhibitors cabotegravir and bictegravir in HIV type 1 non-B subtypes

Neogi U; Singh K; Aralaguppe SG; Rogers LC; Njenda DT; Sarafianos SG; Hejdeman B; Sonnerborg A
Article: SCIENTIFIC REPORTS. 2018;8(1):2363

Phenotypic co-receptor tropism and Maraviroc sensitivity in HIV-1 subtype C from East Africa

Siddik AB; Haas A; Rahman MS; Aralaguppe SG; Amogne W; Bader J; Klimkait T; Neogi U
Article: MEDICINE. 2018;97(5):e9759

Plasma soluble factor following two decades prolonged suppressive antiretroviral therapy in HIV-1-positive males A cross-sectional study

Sperk M; Zhang W; Nowak P; Neogi U
Article: EBIOMEDICINE. 2018;27:40-50

Transcriptomics and Targeted Proteomics Analysis to Gain Insights Into the Immune-control Mechanisms of HIV-1 Infected Elite Controllers

Zhang W; Ambikan AT; Sperk M; van Domselaar R; Nowak P; Noyan K; Russom A; Sonnerborg A; Neogi U
Article: FRONTIERS IN MICROBIOLOGY. 2018;9:1754

Structural Implications of Genotypic Variations in HIV-1 Integrase From Diverse Subtypes

Rogers L; Obasa AE; Jacobs GB; Sarafianos SG; Sonnerborg A; Neogi U; Singh K
Article: FRONTIERS IN MICROBIOLOGY. 2018;9:2358

Characterization of Inducible Transcription and Translation-Competent HIV-1 Using the RNAscope ISH Technology at a Single-Cell Resolution

Zhang W; Akusjarvi SS; Sonnerborg A; Neogi U
Article: HIV MEDICINE. 2017;18(9):677-684

A high rate of HIV-1 acquisition post immigration among migrants in Sweden determined by a CD4 T-cell decline trajectory model

Brannstrom J; Sonnerborg A; Svedhem V; Neogi U; Marrone G
Article: SCIENTIFIC REPORTS. 2017;7(1):6371

Recent increased identification and transmission of HIV-1 unique recombinant forms in Sweden

Neogi U; Siddik AB; Kalaghatgi P; Gisslen M; Bratt G; Marrone G; Sonnerborg A
Article: SCIENTIFIC REPORTS. 2017;7(1):6269

Richer gut microbiota with distinct metabolic profile in HIV infected Elite Controllers

Vesterbacka J; Rivera J; Noyan K; Parera M; Neogi U; Calle M; Paredes R; Sonnerborg A; Noguera-Julian M; Nowak P
Article: SCIENTIFIC REPORTS. 2017;7(1):666

Quantitative humoral profiling of the HIV-1 proteome in elite controllers and patients with very long-term efficient antiretroviral therapy

Zhang W; Morshed MM; Noyan K; Russom A; Sonnerborg A; Neogi U
Article: PLOS ONE. 2017;12(7):e0180140

Effect of therapy switch on time to second-line antiretroviral treatment failure in HIV-infected patients

Haggblom A; Santacatterina M; Neogi U; Gisslen M; Hejdeman B; Flamholc L; Sonnerborg A
Article: JOURNAL OF MEDICAL VIROLOGY. 2017;89(1):106-111

Increased replication capacity following evolution of PYxE insertion in Gag-p6 is associated with enhanced virulence in HIV-1 subtype C from East Africa

Aralaguppe SG; Winner D; Singh K; Sarafianos SG; Quinones-Mateu ME; Soennerborg A; Neogi U
Article: PLOS ONE. 2017;12(6):e0178942

Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy

Svard J; Mugusi S; Mloka D; Neogi U; Meini G; Mugusi F; Incardona F; Zazzi M; Sonnerborg A
Article: JOURNAL OF VIROLOGICAL METHODS. 2016;236:98-104

Multiplexed next-generation sequencing and de novo assembly to obtain near full-length HIV-1 genome from plasma virus

Aralaguppe SG; Siddik AB; Manickam A; Ambikan AT; Kumar MM; Fernandes SJ; Amogne W; Bangaruswamy DK; Hanna LE; Sonnerborg A; Neogi U
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2016;32(5):471-474

Phylogenetic Analysis of Ethiopian HIV-1 Subtype C Near Full-Length Genomes Reveals High Intrasubtype Diversity and a Strong Geographical Cluster

Amogne W; Bontell I; Grossmann S; Aderaye G; Lindquist L; Sonnerborg A; Neogi U
Article: LANCET INFECTIOUS DISEASES. 2016;16(5):565-575

Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

Gregson J; Tang M; Ndembi N; Hamers RL; Rhee S-Y; Marconi VC; Diero L; Brooks K; Theys K; de Wit TFR; Arruda M; Garcia F; Monge S; Gunthard HF; Hoffmann CJ; Kanki PJ; Kumarasamy N; Kerschberger B; Mor O; Charpentier C; Todesco E; Rokx C; Gras L; Halvas EK; Sunpath H; Di Carlo D; Antinori A; Andreoni M; Latini A; Mussini C; Aghokeng A; Sonnerborg A; Neogi U; Fessel WJ; Agolory S; Yang C; Blanco JL; Juma JM; Smit E; Schmidt D; Watera C; Asio J; Kirungi W; Tostevin A; El-Hay T; Clumeck N; Goedhals D; van Vuuren C; Bester PA; Sabin C; Mukui I; Santoro MM; Perno CF; Hunt G; Morris L; Camacho R; de Oliveira T; Pillay D; Schulter E; Murakami-Ogasawara A; Reyes-Teran G; Romero K; Avila-Rios S; Sirivichayakul S; Ruxrungtham K; Mekprasan S; Dunn D; Kaleebu P; Raizes E; Kantor R; Shafer RW; Gupta RK
Article: LANCET HIV. 2016;3(4):e166-e174

Virological failure in patients with HIV-1 subtype C receiving antiretroviral therapy: an analysis of a prospective national cohort in Sweden

Haggblom A; Svedhem V; Singh K; Sonnerborg A; Neogi U
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2016;71(2):367-371

Factors influencing the efficacy of rilpivirine in HIV-1 subtype C in low- and middle-income countries

Neogi U; Haggblom A; Singh K; Rogers LC; Rao SD; Amogne W; Schuelter E; Zazzi M; Arnold E; Sarafianos SG; Sonnerborg A
Article: BMJ OPEN. 2016;6(1):e008795

Can HIV reverse transcriptase activity assay be a low-cost alternative for viral load monitoring in resource-limited settings?

Gupta S; Palchaudhuri R; Neogi U; Srinivasa H; Ashorn P; De Costa A; Kallander C; Shet A
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2016;32(1):80-84

Mutational Heterogeneity in p6 Gag Late Assembly (L) Domains in HIV-1 Subtype C Viruses from South Africa

Neogi U; Engelbrecht S; Claassen M; Jacobs GB; van Zyl G; Preiser W; Sonnerborg A
Article: AIDS. 2015;29(18):2409-2418

Gut microbiota diversity predicts immune status in HIV-1 infection

Nowak P; Troseid M; Avershina E; Barqasho B; Neogi U; Holm K; Hov JR; Noyan K; Vesterbacka J; Svard J; Rudi K; Sonnerborg A
Article: TROPICAL MEDICINE & INTERNATIONAL HEALTH. 2015;20(11):1462-1472

Virological efficacy with first-line antiretroviral treatment in India: predictors of viral failure and evidence of viral resuppression

Shet A; Neogi U; Kumarasamy N; DeCosta A; Shastri S; Rewari BB
Article: JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. 2015;18(1):20035

Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management

Grossmann S; Nowak P; Neogi U
Article: INTERVIROLOGY. 2015;58(1):1-5

Performance of Genotypic Tools for Prediction of Tropism in HIV-1 Subtype C V3 Loop Sequences

Gupta S; Neogi U; Srinivasa H; Shet A
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2014;69(12):3349-3355

Cost-efficient HIV-1 drug resistance surveillance using multiplexed high-throughput amplicon sequencing: implications for use in low- and middle-income countries

Ekici H; Rao SD; Sonnerborg A; Ramprasad VL; Gupta R; Neogi U
Article: BMJ-BRITISH MEDICAL JOURNAL. 2014;349:g5978

Effect of mobile telephone reminders on treatment outcome in HIV: evidence from a randomised controlled trial in India

Shet A; De Costa A; Kumarasamy N; Rodrigues R; Rewari BB; Ashorn P; Eriksson B; Diwan V
Article: INDIAN PEDIATRICS. 2014;51(10):801-803

Genetic Factors Associated with Slow Progression of HIV among Perinatally-Infected Indian Children

Chaudhuri RP; Neogi U; Rao SD; Shet A
Article: AIDS. 2014;28(15):2319-2322

Novel tetra-peptide insertion in Gag-p6 ALIX-binding motif in HIV-1 subtype C associated with protease inhibitor failure in Indian patients

Neogi U; Rao SD; Bontell I; Verheyen J; Rao VR; Gore SC; Soni N; Shet A; Schuelter E; Ekstrand ML; Wondwossen A; Kaiser R; Madhusudhan MS; Prasad VR; Sonnerborg A
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2014;30(6):586-591

Phylogenetic Characterization of Six Full-Length HIV-1 Subtype C Molecular Clones from Three Patients: Identification of Rare Subtype C Strains Containing Two NF-κB Motifs in the Long Terminal Repeat

Hanna LE; Neogi U; Ranga U; Swaminathan S; Prasad VR
Article: JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2014;65(4):397-404

HIV-1 Coreceptor Tropism in India: Increasing Proportion of X4-Tropism in Subtype C Strains Over Two Decades

Gupta S; Neogi U; Srinivasa H; Banerjea AC; Shet A
Article: PLOS ONE. 2014;9(9):e107074

The gp120 Protein Is a Second Determinant of Decreased Neurovirulence of Indian HIV-1C Isolates Compared to Southern African HIV-1C Isolates

Rao VR; Neogi U; Eugenin E; Prasad VR
Article: ANTIVIRAL THERAPY. 2014;19(8):813-818

Limited evolution but increasing trends of primary non-nucleoside reverse transcriptase inhibitor resistance mutations in therapy-naive HIV-1-infected individuals in India

Neogi U; Gupta S; Palchaudhuri R; Rao SD; Shastri S; Diwan V; Laishram RS; De Costa A; Shet A
Article: PLOS ONE. 2014;9(6):e99390

Temporal Trends in the Swedish HIV-1 Epidemic: Increase in Non-B Subtypes and Recombinant Forms over Three Decades

Neogi U; Haggblom A; Santacatterina M; Bratt G; Gisslen M; Albert J; Sonnerborg A
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2013;29(12):1613-1616

Genetic Architecture of HIV Type 1 Nef and Tat from HLA-B57-Typed Long-Term Survivors in an Indian Cohort of Perinatally HIV-Infected Children

Neogi U; Palchaudhuri R; Bommana S; Shet A
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2013;68(9):2003-2006

High concordance of genotypic coreceptor prediction in plasma-viral RNA and proviral DNA of HIV-1 subtype C: implications for use of whole blood DNA in resource-limited settings

Gupta S; Neogi U; Srinivasa H; Shet A
Article: RETROVIROLOGY. 2013;10:61

Clade C HIV-1 isolates circulating in Southern Africa exhibit a greater frequency of dicysteine motif-containing Tat variants than those in Southeast Asia and cause increased neurovirulence

Rao VR; Neogi U; Talboom JS; Padilla L; Rahman M; Fritz-French C; Gonzalez-Ramirez S; Verma A; Wood C; Ruprecht RM; Ranga U; Azim T; Joska J; Eugenin E; Shet A; Bimonte-Nelson H; Tyor WR; Prasad VR
Article: PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2013;32(5):e227-e229

Effectiveness of First-line Antiretroviral Therapy and Acquired Drug Resistance Among HIV-1-infected Children in India

Shet A; Neogi U; Sahoo PN; De Costa A
Article: JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. 2013;16(1):18472

Human APOBEC3G-mediated hypermutation is associated with antiretroviral therapy failure in HIV-1 subtype C-infected individuals

Neogi U; Shet A; Sahoo PN; Bontell I; Ekstrand ML; Banerjea AC; Sonnerborg A
Article: PLOS ONE. 2013;8(1):e55421

Long-Term Efficacy of First Line Antiretroviral Therapy in Indian HIV-1 Infected Patients: A Longitudinal Cohort Study

Neogi U; Heylen E; Shet A; Chandy S; Shamsunder R; Soennerborg A; Ekstrand ML
Article: INTERNATIONAL JOURNAL OF MICROBIOLOGY RESEARCH. 2012;136(6):956-962

Dried blood spot HIV-1 RNA quantification: A useful tool for viral load monitoring among HIV-infected individuals in India

Neogi U; Gupta S; Rodridges R; Sahoo PN; Rao SD; Rewari BB; Shastri S; De Costa A; Shet A
Article: BMC INFECTIOUS DISEASES. 2012;12:317

High viremia and low level of transmitted drug resistance in anti-retroviral therapy-naive perinatally-infected children and adolescents with HIV-1 subtype C infection

Neogi U; Sahoo PN; De Costa A; Shet A
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2012;28(9):1152-1156

Genetic Characterization of HIV Type 1 Tat Exon 1 from a Southern Indian Clinical Cohort: Identification of Unique Epidemiological Signature Residues

Neogi U; Gupta S; Sahoo PN; Shet A; Rao SD; Ranga U; Prasad VR
Article: JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2012;59(4):347-353

Higher Prevalence of Predicted X4-Tropic Strains in Perinatally Infected Older Children With HIV-1 Subtype C in India

Neogi U; Sahoo PN; Arumugam K; Sonnerborg A; De Costa A; Shet A
Article: PLOS ONE. 2012;7(6):e39819

Molecular Epidemiology of HIV-1 Subtypes in India: Origin and Evolutionary History of the Predominant Subtype C

Neogi U; Bontell I; Shet A; De Costa A; Gupta S; Diwan V; Laishram RS; Wanchu A; Ranga U; Banerjea AC; Sonnerborg A
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2011;27(11):1249-1253

Characterization of HIV Type 1 Subtype C protease Gene: Selection of L63P Mutation in Protease Inhibitor-Naive Indian Patients

Neogi U; Sahoo PN; Kumar R; De Costa A; Shet A
Article: AIDS. 2011;25(8):1123-1126

Selection of nonnucleoside reverse transcriptase inhibitor-associated mutations in HIV-1 subtype C: evidence of etravirine cross-resistance

Neogi U; Shet A; Shamsundar R; Ekstrand ML
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2010;26(12):1299-1305

Diversity of HIV Type 1 Long Terminal Repeat (LTR) Sequences Following Mother-to-Child Transmission in North India

Neogi U; Sharma Y; Sood V; Wanchu A; Banerjea AC
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2010;26(10):1097-1101

Naturally Occurring Polymorphisms and Primary Drug Resistance Profile Among Antiretroviral-Naive Individuals in Bangalore, India

Neogi U; Prarthana BS; Gupta S; D'souza G; De Costa A; Kuttiatt VS; Arumugam K; Shet A
Article: AIDS RESEARCH AND THERAPY. 2010;7:28

Genetic and functional analysis of HIV-1 Rev Responsive Element (RRE) sequences from North-India

Sharma Y; Neogi U; Sood V; Banerjee S; Samrat S; Wanchu A; Singh S; Banerjea AC
Article: AIDS RESEARCH AND THERAPY. 2010;7:24

Co-receptor tropism prediction among 1045 Indian HIV-1 subtype C sequences: Therapeutic implications for India

Neogi U; Prarthana SB; D'Souza G; DeCosta A; Kuttiatt VS; Ranga U; Shet A
Article: AIDS RESEARCH AND THERAPY. 2009;6:28

Genetic analysis of HIV-1 Circulating Recombinant Form 02_AG, B and C subtype-specific envelope sequences from Northern India and their predicted co-receptor usage.

Neogi U; Sood V; Chowdhury A; Das S; Ramachandran VG; Sreedhar VK; Wanchu A; Ghosh N; Banerjea AC
Article: JOURNAL OF GENERAL VIROLOGY. 2009;90(Pt 11):2768-2776

Genetic and functional characterization of human immunodeficiency virus type 1 VprC variants from north India: presence of unique recombinants with mosaic genomes from B, C and D subtypes within the open reading frame of Vpr

Bano AS; Sood V; Neogi U; Goel N; Kuttiat VS; Wanchu A; Banerjea AC
Article: BIOINFORMATION. 2009;4(3):90-91

The expanding HIV-1 epidemic aggravates therapeutics and vaccine development programs in India.

Neogi U
Article: ARCHIVES OF VIROLOGY. 2008;153(10):1961-1966

Novel HIV-1 long terminal repeat (LTR) sequences of subtype B and mosaic intersubtype B/C recombinants in North India

Neogi U; Sood V; Goel N; Wanchu A; Banerjea AC
Visa fler

Alla övriga publikationer

Preprint: RESEARCH SQUARE. 2023

Parechovirus infection in human brain organoids: host innate inflammatory response and not neuro-infectivity correlates to neurologic disease

Capendale PE; García-Rodríguez I; Ambikan AT; Mulder LA; Depla JA; Freeze E; Koen G; Calitz C; Sood V; de Sá RV; Neogi U; Pajkrt D; Srid A; Wolthers KC
Preprint: RES SQ. 2023;RES SQ

Proteomic landscape of astrocytes and pericytes infected with HIV/SARS-CoV-2 mono/co-infection, impacting on neurological complications.

Acharya A; Ambikan AT; Thurman M; Malik MR; Dyavar SR; Végvári Á; Neogi U; Byrareddy SN
Preprint: MEDRXIV. 2023

Gut microbiome predicts atopic diseases in an infant cohort with reduced bacterial exposure due to social distancing

Korpela K; Hurley S; Ford SA; Franklin R; Byrne S; Lunjani N; Forde B; Neogi U; Venter C; Walter J; Hourihane J; O’Mahony L
Letter: ALLERGY. 2022;77(5):1623-1625

Metabolic rewiring and serotonin depletion in patients with postacute sequelae of COVID-19

Sadlier C; Albrich WC; Neogi U; Lunjani N; Horgan M; O'Toole PW; O'Mahony L
Review: PHARMACOLOGICAL REPORTS. 2022;74(2):273-296

Antiviral drug research for Japanese encephalitis: an updated review

Joe S; Salam AAA; Neogi U; Babu NN; Mudgal PP
Preprint: HRB OPEN RES. 2022

Impact of Long COVID on health and quality of life

O’ Mahony L; Buwalda T; Blair M; Forde B; Lunjani N; Ambikan A; Neogi U; Barrett P; Geary E; O'Connor N; Dineen J; Clarke G; Kelleher E; Horgan M; Jackson A; Sadlier C
Review: JOURNAL OF PROTEOME RESEARCH. 2020;19(11):4259-4274

Utility of Proteomics in Emerging and Re-Emerging Infectious Diseases Caused by RNA Viruses

Sperk M; van Domselaar R; Rodriguez JE; Mikaeloff F; Vinhas BS; Saccon E; Sonnerborg A; Singh K; Gupta S; Vegvari A; Neogi U
Letter: JOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH. 2020;10(3):192-193

The Association between Out-of-Pocket Expenditure and COVID-19 Mortality Globally

El-Khatib Z; Otu A; Neogi U; Yaya S
Corrigendum: SCIENTIFIC REPORTS. 2020;10(1):13607

In vitro replicative fitness of early Transmitted founder HIV-1 variants and sensitivity to Interferon alpha (vol 10, 2747, 2020)

Ashokkumar M; Sonawane A; Sperk M; Tripathy SP; Neogi U; Hanna LE
Letter: ECLINICALMEDICINE. 2020;23:100430

The disproportionate effect of COVID-19 mortality on ethnic minorities: Genetics or health inequalities?

El-Khatib Z; Jacobs GB; Ikomey GM; Neogi U
Editorial comment: ECLINICALMEDICINE. 2020;18:100251

Following the path: Increasing trends of HIV-1 drug resistance in China

Gupta S; Neogi U
Meeting abstract: VIRUS EVOLUTION. 2019;5:S2

Near full-length HIV-1 genome sequencing in newly diagnosed individuals in Sweden

Andersson E; Aralaguppe S; Thebo L; Sonnerborg A; Neogi U; Albert J
Review: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2018;19(7):E2000-2000

Immune Checkpoints as the Immune System Regulators and Potential Biomarkers in HIV-1 Infection

Sperk M; van Domselaar R; Neogi U
Corrigendum: SCIENTIFIC REPORTS. 2018;8(1):6262

Analyses of HIV-1 integrase sequences prior to South African national HIV-treatment program and availability of integrase inhibitors in Cape Town, South Africa (vol 8, 2018)

Brado D; Obasa AE; Ikomey GM; Cloete R; Singh K; Engelbrecht S; Neogi U; Jacobs GB
Letter: AIDS. 2014;28(17):2635-2636

Minor viral population with drug-resistant mutation and risk of persistent low-level viremia or 'blips' in HIV-1 subtype C

Neogi U; Sonnerborg A
Review: VIRUSES-BASEL. 2014;6(9):3535-3562

Drug Resistance in Non-B Subtype HIV-1: Impact of HIV-1 Reverse Transcriptase Inhibitors

Singh K; Flores JA; Kirby KA; Neogi U; Sonnerborg A; Hachiya A; Das K; Arnold E; McArthur C; Parniak M; Sarafianos SG
Letter: JOURNAL OF INFECTIOUS DISEASES. 2013;208(5):866-867

High Viremia in HIV-1 Subtype C Infection and Spread of the Epidemic

Neogi U; Palchaudhuri R; Shet A
Thesis / dissertation: 2013

Translational genomics of HIV-1 subtype C in India : molecular phylogeny and drug resistance

Neogi, Ujjwal
Meeting abstract: RETROVIROLOGY. 2012;9:p151

Emergence of unique recombinant forms (URFs) in Indian HIV-1 epidemic: data from nationwide clinical cohort between 2007 and 2011

Neogi U; Gupta S; Shet A; De Costa A; Laishram RL; Wanchu A; Diwan V; Banerjea AC; Sonnerborg A
Review: INDIAN JOURNAL OF MEDICAL RESEARCH. 2011;134(6):769-778

Genetic architecture of HIV-1 genes circulating in north India & their functional implications

Neogi U; Sood V; Ronsard L; Singh J; Lata S; Ramachandran VG; Das S; Wanchu A; Banerjea AC
Meeting abstract: RETROVIROLOGY. 2009;6:p375

Emergence of HIV-1 circulatory recombinant forms (CRFs) and unique recombinant forms (URFs) in North India: functional and pathogenic implications

Neogi U; Sood V; Bano AS; Wanchu A; Banerjea AC
Published conference paper: INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY. 2009;47(6):424-431

Global HIV-1 molecular epidemiology with special reference to genetic analysis of HIV-1 subtypes circulating in North India: Functional and pathogenic implications of genetic variation

Neogi U; Sood V; Banerjee S; Ghosh N; Verma S; Samrat S; Sharma Y; Saxena A; Husain S; Ramachandran VG; Das S; Sreedhar VK; Goel N; Wanchu A; Banerjea AC
Review: INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS. 2008;45(3):141-148

Host genes that affect progression of AIDS/HIV in India and novel gene therapeutic approaches against HIV

Sood V; Rathore A; Husain S; Khan S; Patra S; Shankar V; Kumar H; Rani N; Bano AS; Neogi U; Ramachandran VG; Banerjea AC
Visa fler

Forskningsbidrag

Indoor biomass burning contributes to significant particulate matter exposure, chronic human health burden, and an economic drain in rural households

Swedish Research Council

1 January 2023 - 31 December 2026
Potentiating host immuno-metabolism as a novel approach toward reservoir eradication and functional cure in HIV-1 infection

Swedish Research Council

1 December 2021 - 30 November 2025
Comprehensive mapping of metabolic perturbations in emerging and re-emerging RNA viruses for novel therapeutic approaches

Swedish Research Council

1 December 2021 - 30 November 2024
Characterization of susceptibility and resistance to novel categories of anti-HIV compounds

Swedish Research Council

1 January 2021 - 31 December 2023
A clinical trans-omics multidisciplinary study to understand the role of antiretroviral therapy in premature ageing of the immune system in HIV-infection

Swedish Research Council

1 December 2018 - 30 November 2023
A multi-omics system biology approach to identify disease control mechanisms in HIV-1 positive Elite Controllers and the importance for HIV-cure

Swedish Research Council

1 January 2018 - 31 December 2021
Unravilling the mechanisms of natural control and long term successful ART in HIV-1 infection: prospects for HIV-1 cure and vaccine development

Swedish Research Council

1 January 2018 - 31 December 2020
Development of a molecular surveillance phylogeographic tool to track HIV transmission networks in Bangladesh

Swedish Research Council

1 January 2016 - 31 December 2018

Anställningar

Lektor, Laboratoriemedicin, Karolinska Institutet, 2024-

Examina och utbildning

Docent, Virologi, Karolinska Institutet, 2018
Medicine Doktorsexamen, Institutionen för medicin, Huddinge, Karolinska Institutet, 2013

Artiklar

Alla övriga publikationer

Forskningsbidrag

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI